Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 EUR | +4.73% | +0.70% | -21.31% |
Sales 2024 * | 64.79M 69.27M 5.78B | Sales 2025 * | 75.94M 81.2M 6.77B | Capitalization | 62.92M 67.28M 5.61B |
---|---|---|---|---|---|
Net income 2024 * | -5M -5.35M -446M | Net income 2025 * | -2M -2.14M -178M | EV / Sales 2024 * | 1.35 x |
Net Debt 2024 * | 24.4M 26.09M 2.18B | Net Debt 2025 * | 22.75M 24.33M 2.03B | EV / Sales 2025 * | 1.13 x |
P/E ratio 2024 * |
-17.2
x | P/E ratio 2025 * |
-21.2
x | Employees | 311 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.38% |
Latest transcript on BRAIN Biotech AG
1 day | +4.73% | ||
1 week | +0.70% | ||
Current month | -16.52% | ||
1 month | -16.52% | ||
3 months | -22.79% | ||
6 months | -22.99% | ||
Current year | -21.31% |
Managers | Title | Age | Since |
---|---|---|---|
Adriaan Moelker
CEO | Chief Executive Officer | 60 | 01/20/01 |
Director of Finance/CFO | 54 | 01/20/01 | |
Alexander Pelzer
CTO | Chief Tech/Sci/R&D Officer | 38 | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Majerus
CHM | Chairman | 63 | 07/19/07 |
Stephen Catling
BRD | Director/Board Member | 59 | 14/20/14 |
Director/Board Member | 70 | 14/20/14 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 2.88 | +4.73% | 1,078 |
25/24/25 | 2.75 | -1.43% | 1,774 |
24/24/24 | 2.79 | +0.36% | 21,628 |
23/24/23 | 2.78 | -1.07% | 14,114 |
22/24/22 | 2.81 | -1.75% | 14,482 |
Delayed Quote Xetra, April 26, 2024 at 09:06 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.31% | 67.17M | |
-29.08% | 213M |
- Stock Market
- Equities
- BNN Stock